Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy

    December 2007 in “ Current Oncology ”
    Christine Derzko, Stacy Elliott, Wendy Wing Tak Lam
    Studysummary This review discusses management strategies for sexual side effects of aromatase inhibitors in postmenopausal breast cancer patients and reports no original clinical findings.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline The Journal of Clinical Endocrinology and Metabolism · 2006
    2. Endocrine Aspects of Female Sexual Dysfunction The Journal of Sexual Medicine · 2004
    3. Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone Endocrine Reviews · 2003